Understanding Wegovy vs Mounjaro: Complete Price Comparison
Is Wegovy the Same as Mounjaro? Key Mechanism Differences
The fundamental difference between Wegovy and Mounjaro lies in their active ingredients and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single natural hormone involved in appetite regulation. Mounjaro contains tirzepatide, which works as a dual agonist targeting both GIP and GLP-1 receptors, offering a different approach to weight management.
Both are prescription-only medicines requiring clinical assessment, but their different mechanisms may suit different patient profiles. Wegovy has been available longer with extensive clinical data from the STEP trial programme, whilst Mounjaro represents a newer dual-pathway approach. At EverydayMeds (GPhC #9012878), our prescribers can help determine which treatment aligns with your individual circumstances during the clinical assessment process.
Discount Code Pricing: Wegovy vs Mounjaro Cost Comparison
Understanding the cost difference between Wegovy and Mounjaro is crucial when deciding between treatments. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. These prices reflect our discount codes FIRST40 (new customers) and DOSE25 (returning customers) applied at checkout.
Both treatments require dose escalation protocols, but their pricing structures differ significantly. We offer convenient bundle options like our Intro Duo (0.25mg & 0.5mg Wegovy) for £169.99, providing your first two months of treatment. Our Gentle Start Trio at £269.99 includes extended time on the lowest doses for those preferring gradual escalation. Whether you're comparing Wegovy or Mounjaro pricing, our transparent approach ensures you understand exactly what you'll pay at each treatment stage.
Clinical Evidence: Is Wegovy Same as Mounjaro in Effectiveness?
Both Wegovy and Mounjaro have demonstrated significant efficacy in clinical trials, though direct head-to-head comparisons are limited due to different trial designs and populations. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme also demonstrated sustained weight loss over two years in STEP 5.
Mounjaro's SURMOUNT trials showed comparable efficacy through its dual receptor mechanism, though comparing percentage outcomes directly isn't appropriate given different study methodologies. Both medications work alongside a reduced-calorie diet and increased physical activity as part of comprehensive weight management programmes. The choice between treatments often depends on individual patient factors, tolerance profiles, and prescriber recommendations rather than efficacy differences alone.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a natural hormone released after eating. This mechanism helps regulate appetite by acting on brain centres responsible for hunger and satiety signals. Patients typically experience reduced appetite and increased feelings of fullness after smaller meals, supporting portion control efforts. The medication may also reduce food cravings and the psychological drive to eat, complementing dietary modifications. Unlike some weight management approaches, Wegovy works through established hormonal pathways that naturally regulate energy balance, making it a physiologically-based treatment option when used alongside lifestyle modifications.
Ordering Process: Accessing Wegovy vs Mounjaro Through EverydayMeds
Whether you're considering Wegovy or Mounjaro, our streamlined ordering process ensures safe, legal access to both treatments. The journey begins with our 3-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our qualified prescribers review each assessment thoroughly, typically within 3 working days (express 24-hour service available). Once approved, your medication ships via next-day delivery using cold-chain transportation to maintain temperature integrity. Both treatments arrive with comprehensive injection guidance, dose escalation schedules, and ongoing support information to ensure safe, effective use throughout your weight management journey.
Storage and Practical Differences: Wegovy vs Mounjaro Convenience
Storage requirements represent a practical consideration when comparing Wegovy and Mounjaro, particularly for frequent travellers. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature stability. Both medications require refrigeration at 2-8°C before first use and utilise pre-filled pen injectors for convenience. Wegovy uses Novo Nordisk's FlexTouch pen system with dose escalation from 0.25mg to 2.4mg over 16 weeks, whilst Mounjaro follows its own escalation protocol. The extended room temperature stability of Wegovy may benefit patients with active lifestyles or travel commitments, though both treatments accommodate most lifestyle requirements effectively.
Is Wegovy Same as Mounjaro for Different Patient Profiles?
Patient suitability often determines whether Wegovy or Mounjaro represents the optimal choice, as individual response patterns can vary significantly. Some patients may respond better to Wegovy's single-pathway GLP-1 mechanism, whilst others might benefit from Mounjaro's dual receptor approach. Factors including previous medication responses, concurrent health conditions, and individual tolerance profiles influence treatment selection. Cost considerations also play a role, with our discount codes FIRST40 and DOSE25 making both options accessible.
Our prescribers evaluate each patient's complete medical picture during assessment, considering not just BMI requirements but also diabetes status, cardiovascular health, and previous weight management attempts. Neither medication is inherently superior—the question isn't whether Wegovy is the same as Mounjaro, but which aligns better with your individual circumstances. Both represent evidence-based approaches to weight management when used as part of comprehensive lifestyle modification programmes.
Maximise Savings: Discount Codes for Both Wegovy and Mounjaro
Accessing either treatment affordably requires understanding our discount code system and pricing structure. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 to reach our competitive pricing. These codes work for both Wegovy and Mounjaro orders, ensuring consistent savings regardless of which treatment your prescriber recommends. Bundle options provide additional convenience, with our Progress Trio (0.5mg, 1mg & 1.7mg) offering three months of progressive dosing for £369.99. Remember, the prices displayed already reflect discount code savings—simply apply your appropriate code (FIRST40 or DOSE25) at checkout to access these rates. Both treatments qualify for our next-day delivery service and come with comprehensive support materials. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to determine which option suits your weight management goals. Whether you choose Wegovy or Mounjaro, our GPhC-registered pharmacy ensures safe, legal access to prescription-only medicines with ongoing clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
